These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 23091600)

  • 1. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
    PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients.
    Logozzi M; Angelini DF; Iessi E; Mizzoni D; Di Raimo R; Federici C; Lugini L; Borsellino G; Gentilucci A; Pierella F; Marzio V; Sciarra A; Battistini L; Fais S
    Cancer Lett; 2017 Sep; 403():318-329. PubMed ID: 28694142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum β2-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer.
    Zhang YX; Wang L; Ji PY; Zhao GG; Zhong GP; Wang ZP
    Arch Med Res; 2013 May; 44(4):259-65. PubMed ID: 23707648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
    Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnostic value of survivin and its alternative splice variants in breast cancer.
    Khan S; Bennit HF; Turay D; Perez M; Mirshahidi S; Yuan Y; Wall NR
    BMC Cancer; 2014 Mar; 14():176. PubMed ID: 24620748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer-Evidence from Serbian Population.
    Matijašević Joković S; Korać A; Kovačević S; Djordjević A; Filipović L; Dobrijević Z; Brkušanin M; Savić-Pavićević D; Vuković I; Popović M; Brajušković G
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented immunoexpression of survivin correlates with parameters of aggressiveness in prostate cancer.
    Danilewicz M; Stasikowska-Kanicka O; Wągrowska-Danilewicz M
    Pol J Pathol; 2015 Mar; 66(1):44-8. PubMed ID: 26017879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the plasma level of long non-coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients.
    Rezatabar S; Moudi E; Sadeghi F; Khafri S; Kopi TA; Parsian H
    J Gene Med; 2020 Oct; 22(10):e3239. PubMed ID: 32529802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
    Joković SM; Dobrijević Z; Kotarac N; Filipović L; Popović M; Korać A; Vuković I; Savić-Pavićević D; Brajušković G
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
    Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D
    J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
    Kharmate G; Hosseini-Beheshti E; Caradec J; Chin MY; Tomlinson Guns ES
    PLoS One; 2016; 11(5):e0154967. PubMed ID: 27152724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significance.
    Gu J; Ren L; Wang X; Qu C; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(11):14034-9. PubMed ID: 26823716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.
    Adeola HA; Smith M; Kaestner L; Blackburn JM; Zerbini LF
    Oncotarget; 2016 Mar; 7(12):13945-64. PubMed ID: 26885621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
    Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
    J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
    Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
    Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.
    Li Q; Hu J; Shi Y; Xiao M; Bi T; Wang C; Yan L; Li X
    Cell Cycle; 2021 Dec; 20(23):2531-2546. PubMed ID: 34724861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.